55453-87-7: Olopatadine Related Compound C

Status: In-stock

$49.00 - 300mg

Also known as Isoxepac, is an impurity present in Olopatadine which is currently being developed as a new anti-inflammatory agent and is a relatively new selective H1 antagonist that has mast cell stabilizing properties and has been shown to affect the release of TNFa and various cytokines from conjunctival epithelial cells.

*COA and Characterication data is always included with the product.
**This product is impurity reference standard for quantitative use.

Additional information on CAS 55453-87-7

Catalogue No. VL720004
CAS No. 55453-87-7
Molecular Formula C₁₆H₁₂O₄
Molecular Weight 268.26
Parent drug Olopatadine
IUPAC Name 6, 11-Dihydro-11-oxo-dibenz[b, e]oxepin-2-acetic Acid
Pharmacopoeial Synonyms N/A
Other Synonyms 2-(11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid; 2-(11-oxo-6H-benzo[c][1]benzoxepin-2-yl)acetic acid; (11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic Acid (Isoxepac)
References Bryce, T. A., and J. L. Burrows. “Quantitative Analysis of 6, 11-Dihydro-11-Oxo-Dibenz[B, E] Oxepin-2-Acetic Acid (Isoxepac) in Plasma and Urine by Gas-Liquid Chromatography.” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 145, no. 3, May 1978, pp. 393–400, https://doi.org/10.1016/s0378-4347(00)81368-7.? McGill, James. “A Review of the Use of Olopatadine in Allergic Conjunctivitis.” International Ophthalmology, vol. 25, no. 3, Springer Science+Business Media, May 2004, pp. 171–79, https://doi.org/10.1007/s10792-004-1818-x. Accessed 26 Oct. 2023. ‌
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

55453-87-7: Olopatadine Related Compound C

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.